Толщина комплекса интима-медиа общих сонных артерий и Q192R-полиморфизм гена параоксоназы-1 у больных абдоминальным ожирением.
Аннотация
Об авторах
О. Д. БеляеваРоссия
А. В. Березина
Россия
Е. А. Чубенко
Россия
Т. Л. Каронова
Россия
А. Р. Волкова
Россия
Е. А. Баженова
Россия
С. Н. Козлова
Россия
В. И. Ларионова
Россия
Н. И. Ананьева
Россия
М. . Вайшали
Россия
Е. И. Баранова
Россия
О. А. Беркович
Россия
Список литературы
1. Благосклонная, Я. В. Эндокринология: учеб. для мед. вузов / Я. В. Благосклонная, Е. В. Шляхто, А. Ю. Бабенко. - СПб.: СпецЛит, 2004. - 398 с.
2. Горшунская, М. Ю. Ассоциация полиморфизма Q192R гена PON1 с сахарным диабетом тип 2 / М. Ю. Горшунская [и др.] // Проблеми ендокринноi патологИ. - 2009. - № 4. - С. 5-11.
3. Мамедов, М. Н. Метаболический синдром - больше, чем сочетание факторов риска: принципы диагностики и лечения / М. Н. Мамедов. - М.: Верваг фарма, 2006. - С. 7-42.
4. Practice Guidelines for the Management of Arterial Hypertension ESH-ESC//J. of Hypertension. - 2007. - Vol. 25. - Р. 1751-1762.
5. Alberti, G. Introduction to the metabolic syndrome / G. Alberti // Eur. Heart J. - 2005. - Vol. 7 (Supplement D). - P. D3-D5.
6. Aubo, C. Risk of myocardial infarction with Gln/ Arg 192 polymorphisms in the human paraoxonase gene and diabetes mellitus / C. Aubo [et al] //Eur. Heart J. - 2000. - Vol. 21. - Р. 31-38.
7. Aviram, M. Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective active of human paraoxonase alloenzymes Q andR /M. Aviram [et al]//Arterioscler Thromb Vasc Biol. - 1998. - Vol. 10. - Р. 1617-1624.
8. Bots, M. L. Intima media thickness as a surrogate marker for generalised atherosclerosis / M. L. Bots, D. E. Grobber // Cardiovasc Drug Ther. - 2002. - Vol. 16. - P. 341-351.
9. Cao, H. Lack of association between carotid intima- media thickness and paraoxonase gene polymorphism in noninsulin dependent diabetes mellitus / H. Cao [et al] // Atherosclerosis. - 1998. - Vol. 138 - P. 361-366.
10. Clarimon, J. Paraoxonase 1 (PON1) gene polymorphisms and Parkinson's disease in a Finnish population / J. Clarimon [et al] // Neurosci. Lett. - 2004 - Vol. 36. - Р. 168-170.
11. Czernichow, S. Body composition and fat repartition in relation to structure and function of large arteries in middle- aged adults (the SU.VI.MAX study) / S. Czernichow [et al] // Int J Obes (Lond). - 2005. - Vol. 29. - P. 826-832.
12. Gardemann, A. The paraoxonase Leu-Met54 and Gln-Arg191 gene polymorphisms are not associated with the risk of coronary heart disease / A. Gardemann [et al] // Atherosclerosis. - 2000. - Vol. 152. - Р. 421-431.
13. Gnasso, A. The Arg allele in position 192 of PON1 is associated with carotid atherosclerosis in subjects with elevatedHDLs/A. Gnasso [et al]//Atherosclerosis. - 2002. - Vol. 164. - Р. 289-295.
14. Humbert, R. The molecular basis of the human serum paraoxonase activity polymorphism / R. Humbert [et al]. - Nat Genet. - 1993. - Vol. 3. - Р. 73-76.
15. Imai, Y. Evidencefor association between paraoxonase gene polymorphisms and atherosclerotic diseases / Y. Imai [et al] //Atherosclerosis. - 2000. - Vol. 149. - Р. 435-442.
16. Jureti, D. Paraoxonase/arylesterase in serum of patients with type II diabetes mellitus/ D. Jureti [et al] // Acta Pharm. - 2006. -№ 56. - Р. 59-68.
17. Kawamoto, R. Association of obesity and visceralfat distribution with intima-media thickness of carotid arteries in middle-aged and older persons /R. Kawamoto [et al] // Intern. Med. - 2008. - Vol. 47 (3). - P. 143-149.
18. Kinumi, Т. Proteomic characterization of oxidative dysfunction in human umbilical vein endothelial cells (HUVEC) induced by exposure to oxidized LDL / T. Kinumi [et al] // Free Radic. Res. - 2005. - Vol. 39. - № 12. - Р. 1335-1344.
19. Krauss, R. Metabolic abnormalities: triglyceride and low-density lipoprotein / R. Krauss, P. Siri //Endocrinol. Metab. Clin. N. Am. - 2004. - Vol. 33. - P. 405-415.
20. Lamarche, B. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study / B. Lamarche [et al] // Circulation. - 1997. - Vol. 95. - P. 69-75.
21. Lawlor, D. A. The association of the PON1 Q192R polymorphism with coronary heart disease: findings from the British Women's Heart and Health cohort study and a metaanalysis /D. A. Lawlor [et al] //BMC Genet. - 2004. - Vol. 5. - P. 17.
22. Leus, F. R. PON2 gene variants are associated with clinical manifestations of cardiovascular disease in familial hypercholesterolemia patient / F. R. Leus [et al] // Atherosclerosis. - 2001. - Vol. 154. - Р. 641-649.
23. Lo, J. Effects of obesity, body composition, and adiponectin on carotid intima-media thickness in healthy women / J. Lo [et al] // J. Clin. Endocrinol. Metab. - 2006. - Vol. 91. - P. 1677-1682.
24. Mackness, M. Paraoxonase 1 and atherosclerosis: is the gene or the protein more important? /M. Mackness, S. Mackness //Free Radic Biol Med. - 2004. - Vol. 37. - № 9. - P. 1317-1323.
25. Mackness, M. I. Paraoxonase prevents ac-cumulation of lipoperoxides in low-density lipoprotein /M. I. Mackness, S. Arrol, P. N. Durrington // FEBS Lett. - 1991. - Vol. 286. - Р. 152-154.
26. Mackness, M. I. Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins /M. I. Mackness [et al] // Curr Opin Lipidol. - 1996. - Vol. 7. - Р. 69-76.
27. Maher, V. Association of central obesity with early carotid intima media thickness is independent of that from other risk factors / V. Maher [et al] // Int. J. of Obesity. - 2009. - Vol. 33. - P. 136-143.
28. Manolio, T. A. Genetics of Ultrasonographic Carotid Atherosclerosis / T. A. Manolio [et al]// Arterioscler. Thromb. Vasc. Biol. - 2004. - Vol. 24. - P. 1567-1577.
29. Markus, H. Increased common carotid intima-media thickness in UK African Caribbeans and its relation to chronic inflammation and vascular candidate gene polymorphisms / H. Markus [et al] // Stroke. - 2001. - Vol. 32. - P. 2465-2471.
30. Matthews, D. R. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man /D. R. Matthews [et al] //Diabetologia. - 1985. - Vol. 28 (7). - Р. 412-419.
31. Pati, N. Paraoxonase gene polymorphism and coronary artery disease in Indian subjects / N. Pati, U. Pati // Inter. J. Cardiol. - 1998. - Vol. 66. - Р. 165-168.
32. Primo-Parmo, S. L. The human serum paraoxonase/ arylesterase gene (PON1) is one member of a multigene family / S. L. Primo-Parmo [et al] // Genomics. - 1996. - Vol. 33. - Р. 498-507.
33. Reed, D. Abdominal obesity and carotid artery wall thickness. The Los Angeles Atherosclerosis Study / D. Reed [et al] // Int. J. Obes. Relat. Metab. Disord. - 2003. - Vol. 27. - P. 1546-1551.
34. Ryden, L. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary / L. Ryden [et al] // Eur. Heart J. - 2007. - Vol. 28. - P. 88-136.
35. Sakai, T. Serum paraoxonase activity and genotype distribution in Japanese patients with diabetes mellitus / T. Sakai, B. Matsuura, M. Onji //Intern Med. - 1998. Vol. 37. - Р. 581-584.
36. Senti, M. Antioxidant Paraoxonase 1 Activity in the Metabolic Syndrome /M. Senti [et al] // J. Clin. Endocrinol. Metab. - 2003. - Vol. 88. - Р. 5422-5426.
37. Tomas, M. The antioxidant function of high density lipoproteins: a new paradigm in atherosclerosis / M. Tomas [et al] //Rev. Esp. Cardiol. - 2004. - Vol. 57. - № 6. - Р. 557-569.
Рецензия
Для цитирования:
Беляева О.Д., Березина А.В., Чубенко Е.А., Каронова Т.Л., Волкова А.Р., Баженова Е.А., Козлова С.Н., Ларионова В.И., Ананьева Н.И., Вайшали М..., Баранова Е.И., Беркович О.А. Толщина комплекса интима-медиа общих сонных артерий и Q192R-полиморфизм гена параоксоназы-1 у больных абдоминальным ожирением. Регионарное кровообращение и микроциркуляция. 2011;10(1):46-52. https://doi.org/10.24884/1682-6655-2011-10-1-46-52